NOVEL COMPOUNDS FOR MEDICAL USE AS PEPTIDASE EFFECTORS

PROBLEM TO BE SOLVED: To provide a novel compound which can concertedly inhibit ectoenzymes dipeptidyl peptidase IV (DPIV) and alanyl aminopeptidase (APN) cooperatively.SOLUTION: The compound is a compound of formula (I) or an acid addition salt with an organic acid and/or inorganic acid. (In the fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ANSORGE SIEGFRIED, BANK UTE, TAEGER MICHAEL, NORDHOFF CARSTEN, JULIUS HEIKO, HEIMBURG ANTJE
Format:	Patent
Sprache:	eng
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a novel compound which can concertedly inhibit ectoenzymes dipeptidyl peptidase IV (DPIV) and alanyl aminopeptidase (APN) cooperatively.SOLUTION: The compound is a compound of formula (I) or an acid addition salt with an organic acid and/or inorganic acid. (In the formula, residues R1, R2, R3 and R4 may be the same or different, -H, >C(=O), -C(=O)O- and the like; E represents -O-, -S-, -NH- and the like; Y represents -O-, -NH- and the like; B represents an alkyl substituted group or an alkoxy substituted group having an aryl group or a heterocyclic ring; and C represents a substitution group having amide bond or sulfonamide bond).